0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Theodore J. Cicero, PhD; Matthew S. Ellis, MPE; Hilary L. Surratt, PhD; et al.
JAMA Psychiatry. 2014;71(7):821-826. doi:10.1001/jamapsychiatry.2014.366.
Includes: CME

Original Article |  FREE
Mark Olfson, MD, MPH; Steven C. Marcus, PhD
Arch Gen Psychiatry. 2009;66(8):848-856. doi:10.1001/archgenpsychiatry.2009.81.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Medical News & Perspectives  | 
CDC: Major Disparities in Opioid Prescribing Among States:  Some States Crack Down on Excess Prescribing
Bridget M. Kuehn, MSJ
JAMA Internal Medicine
Viewpoint  | 
Proposed US Food and Drug Administration Guidance for Industry on Distributing Medical Publications About the Risks of Prescription Drugs and Biological Products:  A Misguided Approach
Sidney M. Wolfe, MD
JAMA Internal Medicine
Editor's Note  | 
Restricting Interactions With Industry to Promote Evidence-Based Prescribing
Joseph S. Ross, MD, MHS
JAMA Internal Medicine
Original Investigation  | 
Association of Marketing Interactions With Medical Trainees’ Knowledge About Evidence-Based Prescribing:  Results From a National Survey
Kirsten E. Austad, MD; Jerry Avorn, MD; Jessica M. Franklin, PhD; et al.